UK Markets open in 3 hrs 24 mins
NIKKEI 225
27,521.04 -85.42 (-0.31%) HANG SENG
21,356.79 +73.27 (+0.34%) CRUDE OIL
78.40 -0.07 (-0.09%) GOLD FUTURES
1,891.00 +0.30 (+0.02%) DOW
33,949.01 -207.68 (-0.61%) BTC-GBP
18,686.84 -670.31 (-3.46%)
Xvivo Perfusion AB (publ) (0RKL.L)
LSE - LSE Delayed price. Currency in SEK
Add to watchlist
At close: 04:54PM GMT
| Previous close | 253.89 |
| Open | 0.00 |
| Bid | 0.00 x 0 |
| Ask | 0.00 x 0 |
| Day's range | 0.00 - 0.00 |
| 52-week range | |
| Volume | |
| Avg. volume | N/A |
| Market cap | 6.521B |
| Beta (5Y monthly) | 1.93 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -1.61 |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- ACCESSWIRE
Christoffer Rosenblad appointed as CEO of XVIVO
XVIVO Perfusion AB (STO:XVIVO) (LSE:0RKL) (FRA:3XV) The board of XVIVO Perfusion AB (publ) ("XVIVO") has appointed Christoffer Rosenblad as CEO.
- ACCESSWIRE
XVIVO Completes the Acquisition of the Machine and Perfusion Business from Avionord S.r.l.
XVIVO Perfusion AB (STO:XVIVO)(LSE:0RKL)(FRA:3XV) XVIVO Perfusion AB (publ) ("XVIVO") has today on November 30, 2022, completed the acquisition of all shares in XVIVO S.rl., acquired from XVIVO S.r.l., whose operations were transferred from Avionord S.r.l.
- ACCESSWIRE
XVIVO Strengthens its Executive Management Team by Appointing Lena Hagman to Chief Operating Officer, COO
XVIVO Perfusion AB (STO:XVIVO) (LSE:0RKL) (FRA:3XV) XVIVO continues to build and strengthen the company.
© 2023 Yahoo. All rights reserved.
